Sunitinib

Sunitinib is a cancer medicine that blocks the growth and spread of cancerous cells in the body. It is used to treat types of tumors of the kidney, pancreas and digestive system.

Ensure to notify your doctor if you experience any side effect on using this medication. Certain adverse reactions that may come with using Sunitinib include breathlessness, redness or sunburn, abnormal bleeding from the nose or rectum or vagina or mouth, a sudden increase in blood pressure, irregular periods, depression, rapid heartbeat, tremors, sweating, nausea, vomiting, skin reactions, indigestion, swelling of body parts, muscular or joint pains.

Notify your doctor if you have any liver disorders as Sunitinib may have fatal or severe reactions on your liver. Before using this medication you should notify your doctor if: you have high blood pressure or kidney disorder or heart diseases or blood-clotting disorders, you have history of thyroid or long QT syndrome or heart attack or stroke, you are taking any other medications and if you are pregnant or are nursing a baby.

The usual dose in adults for treating renal cell carcinoma is 50 mg orally once daily for 4 weeks. Dosage should be ideally prescribed by the doctor.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Kidney Cancer

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Nausea

• Vomiting

• Weakness

• Edema (Swelling)

• Rash

• Abdominal Pain

• Loss Of Appetite

• Dyspepsia

• Discoloration Of Skin

• Fatigue

• Fever

• Dry Skin

• Bleeding

• Increased Blood Pressure

• Diarrhoea

• Constipation

• Hand-Foot Syndrome

• Stomatitis (Inflammation Of The Mouth)

• Hair Discolouration

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Is It safe with alcohol?

  Interaction with alcohol is unknown. Please consult your doctor.

• Are there any pregnancy warnings?

  Suninat 50mg capsule is unsafe to use during pregnancy.
  There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.

• Are there any breast-feeding warnings?

  Suninat 50mg capsule is probably unsafe to use during breastfeeding. Please consult your doctor.

• Is it safe to drive while on this medicine?

• Does this affect kidney function?

  There is no interaction between renal impairment and consuming this drug. So dose alteration is not needed.

• Does this affect liver function?

  There is no data available. Please consult doctor before consuming the drug.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Are there any missed dose instructions?

  If you miss a dose of Sunitinib, skip it and continue with your normal schedule. Do not double the dose.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

Below is the list of medicines, which contains Sunitinib as ingredient

• Sutent 12.5Mg Capsule

  Pfizer Ltd

• Suninat 50Mg Capsule

  Natco Pharma Ltd

• Sutent 25Mg Capsule

  Pfizer Ltd

• Sutent 50Mg Capsule

  Pfizer Ltd

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

Sunitinib causes inhibition to many RTKs. These are involved when it comes to growth of tumor, metastatic progression of cancer and pathologic angiogenesis. Sunitinib has been found to cause inhibition to platelet-derived growing receptors. Stem cell receptors, vascular endothelial growth receptors, stem cell receptors, colony stimulating receptors and Fms-like tyrosine kinase-3.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Sunitinib-Drug Information Portal [Internet].druginfo.nlm.nih.gov 2022 [Cited 16 June 2022].Available from:

  https://druginfo.nlm.nih.gov/drugportal/name/sunitinib

• Sunitinib-DrugBank Online [Internet].go.drugbank.com 2022 [Cited 16 June 2022].Available from:

  https://go.drugbank.com/drugs/DB01268

• SUNITINIB capsule,solution-DailyMed [Internet].dailymed.nlm.nih.gov 2022 [Cited 16 June 2022].Available from:

  https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=SUNITINIB